University of California San Francisco
Leaders of the University of California, including UCSF Chancellor Sue Desmond-Hellmann, are condemning the acts of racism, intolerance and incivility after a few incidents at some UC campuses. <a>Read their statement on the UC website</a>.
UCSF Chancellor Sue Desmond-Hellmann today updated the University community on the progress of the administrative and operating efficiencies work group.
A specific region of the hippocampus, a brain structure that is essential to memory, is significantly smaller in veterans with post-traumatic stress disorder than in those without the condition, according to a study by researchers at the San Francisco VA Medical Center and UCSF.
A panel of experts appointed by Mayor Gavin Newsom recently presented an action plan as the approaching “age wave may bring a potential crisis in Alzheimer’s and dementia care” to San Francisco.
UCSF researchers have identified a molecular mechanism that explains why patients with tumors of the thymus, or thymoma, often develop autoimmune disorders.
John Greenspan, whose dental and oral health research has led to major contributions to HIV research and care, is the recipient of the 2010 American Association for Dental Research Distinguished Scientist Award.
Two doctors are now accepting patients at a new primary care group practice at UCSF’s Mount Zion campus.
Senator Arlen Specter visited UCSF last week talking about health care reform -- the topic of today’s nationally televised summit in Washington DC.
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
Gary Schlimgen, director of pension and retirement programs at the University of California Office of the President, answers questions about the restart of contributions to the UC Retirement Plan. <a href="http://www.universityofcalifornia.edu/news/article/22856">Read more on the UC website</a>.
UCSF Chancellor Sue Desmond-Hellmann, MD, MPH, today named Jeffrey Bluestone as executive vice chancellor and provost, pending approval by the UC Regents.
A new discovery about cancer and the immune system points to previously unrecognized targets for drug development to battle solid tumors.
Mission Bay Capital, LLC, has added a new limited partner to its first venture fund, bolstering the fund’s ability to invest in promising bioscience companies emerging from the University of California.
Kimbery Topp, chair of the Department of Physical Therapy and Rehabilitation Science, has been named a fellow of the American Association of Anatomists.
Walter S. Newman, a leading San Francisco businessman, philanthropist, and community leader, has joined the Board of Directors of NCIRE-The Veterans Health Research Institute.
UCSF has launched a family-friendly web portal and is conducting a survey on family needs with the goal of increasing the availability and access of family programs, services and events.
Nominations for the Chancellor’s Award for Gay, Lesbian, Bisexual and/or Transgender (GLBT) Leadership are due by 5 p.m. on March 31.
UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the <i>American Journal of Transplantation</i> that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.